We classified breast cancer patients into different types, and the results showed that high levels of tumor MARCH5 expression had a lower overall survival rate in patients with invasive breast cancer (p = 0.006) (Figure 3F), which also suggests that MARCH5 may have a potential role in regulating the carcinogenesis of breast cancer. This evidence concerns the gene MARCHF5 and breast carcinoma.